Filtered By:
Management: Insurers
This page shows you your search results in order of date. This is page number 15.
Order by Relevance | Date
Total 746 results found since Jan 2013.
Fight Aging! Newsletter, November 27th 2017
We examined associations between mortality and accelerometer-measured PA using age-relevant intensity cutpoints in older women of various ethnicities.
The results support the hypothesis that higher levels of accelerometer-measured PA, even when below the moderate-intensity threshold recommended in current guidelines, are associated with lower all-cause and CVD mortality in women aged 63 to 99. Our findings expand on previous studies showing that higher self-reported PA reduces mortality in adults aged 60 and older, specifically in older women, and at less than recommended amounts. Moreover, our findings challenge th...
Source: Fight Aging! - November 26, 2017 Category: Research Authors: Reason Tags: Newsletters Source Type: blogs
Who Owns Your FitBit Data? Biometric Data Privacy Problems
By JASON CHUNG
The following blog post is adapted from a talk the author gave at the “Data Privacy in the Digital Age” symposium on October 26th sponsored by the U.S. Department Health and Health and Human Services.
Today, I’ll be focusing on the data privacy issues posed by sports wearables, which I define to include both elite systems such as WHOOP or Catapult and more consumer-oriented products such as Fitbits, and why the U.S. needs an integrated federal regulatory framework to address the privacy challenges posed by private entities commercializing biometric data.
Sports wearables have evolved from mere ...
Source: The Health Care Blog - November 25, 2017 Category: Consumer Health News Authors: John Irvine Tags: Uncategorized Biometric Data Privacy Fitbit Source Type: blogs
James Peyer at TEDxStuttgart: Can We Defeat the Diseases of Aging?
My attention was drawn today to a recently published presentation by James Peyer. He heads up Apollo Ventures, one of the new crop of investment concerns focused on funding companies that are developing means to treat aging. These include the Longevity Fund, first out of the gate some years ago, as well as Juvenescence and the Methuselah Fund, created this year, and a repurposing of existing funds, such as Michael Greve's Kizoo ventures. Apollo Ventures is the source of the Geroscience online magazine that helps to advance and explain the position taken on aging by this group; this is something that more investors should d...
Source: Fight Aging! - November 23, 2017 Category: Research Authors: Reason Tags: Healthy Life Extension Community Source Type: blogs
Purging Healthcare of Unnatural Acts
BY UWE REINHARDT
In tribute to Uwe we are re-running this instant classic from THCB’s archives. Originally published on Jan 31, 2017.
Everyone knows (or should know) that forcing a commercial health insurer to write for an individual a health insurance policy at a premium that falls short of the insurer’s best ex ante estimate of the cost of health care that individual will require is to force that insurer into what economists might call an unnatural act.
Remarkably, countries that rely on competing private health insurers to operate their universal, national health insurance systems all do just that. They allow...
Source: The Health Care Blog - November 21, 2017 Category: Consumer Health News Authors: John Irvine Tags: Repeal Replace Trending Uwe Reinhardt Source Type: blogs
ICER Expanding Probe
A nonprofit group, the Institute for Clinical and Economic Review (ICER), recently received a three-year $13.9 million grant from the Laura and John Arnold Foundation to expand its ongoing investigative scope on drug pricing to include all new medicines and price increases on existing treatments.
Up until now, ICER hasn’t had the resources to review all new medicines. The additional funding “puts us on a new trajectory,” according to Steven D. Pearson, president of ICER. “Now we’re going to be able to cover the landscape.”
ICER was essentially founded with a $5.3 million grant from the Arnold Foundation in 20...
Source: Policy and Medicine - November 21, 2017 Category: American Health Authors: Thomas Sullivan - Policy & Medicine Writing Staff Source Type: blogs
Good doctoring transcends numbers
Measuring metrics is a common catch-phrase in health care. The goal of capturing certain data is to improve patient outcomes. But, as doctors, we were taught to treat the patient and not the numbers. While optimizing clinical outcomes is a needed goal with all the complexities in medical treatment currently, the system seems to have gone too far in its quest for targeted numbers.
If, for example, a patient suffers metastatic breast cancer, the insurance company sees them as some variation of the ICD 10 code C50.919 (malignant neoplasm of unspecified site of unspecified breast). The treatments and diagnostic tests are then ...
Source: Kevin, M.D. - Medical Weblog - November 20, 2017 Category: General Medicine Authors: < a href="https://www.kevinmd.com/blog/post-author/linda-girgis" rel="tag" > Linda Girgis, MD < /a > Tags: Physician Diabetes Endocrinology Primary Care Source Type: blogs
Hospitals are struggling and the future is grim
This article, part two of a series that began with a look at primary care disruption, examines the economic struggles of inpatient facilities, the even harsher realities in front of them, and why hospitals are likely to aggravate, not address, health care’s rising cost issues.
According to the Harvard Business Review, several big-name hospitals reported significant declines and, in some cases, net losses to their FY 2016 operating margins. Among them, Partners HealthCare, New England’s largest hospital network, lost $108 million; the Cleveland Clinic witnessed a 71 percent decline in operating income; and MD Anderson...
Source: Kevin, M.D. - Medical Weblog - November 20, 2017 Category: General Medicine Authors: < a href="https://www.kevinmd.com/blog/post-author/robert-pearl" rel="tag" > Robert Pearl, MD < /a > Tags: Policy Hospital-Based Medicine Public Health & Washington Watch Source Type: blogs
Just Because We Can, Doesn ' t Mean We Should, And Who Pays For It
Back when I was first diagnosed with breast cancer, I first learned about the OncotypeDx genomic test for women with breast cancer. Of course I was not eligible for it. I can ' t remember why - whether it was because it wasn ' t my first cancer, or I had a single tiny positive node.I am never eligible for anything because my health is too complicated to be eligible for anything. I have way too many ailments, previous or current treatments, or something. But I digress.I watched all these other women get the tests to find out their risk of recurrence. Over the years, genomic testing has expanded from the OncotypeDx test to i...
Source: Caroline's Breast Cancer Blog - November 16, 2017 Category: Cancer & Oncology Tags: breast cancer treatment cancer diagnosis emotional toll genomic tests Source Type: blogs
The triangle of blame for the opioid epidemic
Prescription opioid abuse is one of the United States’ greatest public health challenges. Approximately 97.5 million Americans consume opioids annually, and around 90 people die every day from opioid overuse. The last time in recent history a health care crisis garnered this much public attention was following the release of the 1964 “Surgeon General’s Report on Smoking and Health” correlating smoking to heart disease and cancer. Today, we hear stories like a coroner reporting — for the second time this year — that he has run out of storage space for bodies due to rising opioid overdose deaths. Such stori...
Source: Kevin, M.D. - Medical Weblog - November 14, 2017 Category: General Medicine Authors: < a href="https://www.kevinmd.com/blog/post-author/sangrag-ganguli-and-uche-ezeh" rel="tag" > Sangrag Ganguli and Uche Ezeh < /a > Tags: Policy Pain Management Primary Care Public Health & Source Type: blogs
Why Hospitals Are Losing Serious Money And What That Means For Your Future
This article examines the economic struggles of inpatient facilities, the even harsher realities in front of them, and why hospitals are likely to aggravate, not address, healthcare’s rising cost issues.
According to the Harvard Business Review, several big-name hospitals reported significant declines and, in some cases, net losses to their FY 2016 operating margins. Among them, Partners HealthCare, New England’s largest hospital network, lost $108 million; the Cleveland Clinic witnessed a 71% decline in operating income; and MD Anderson, the nation’s largest cancer center, dropped $266 million.
How did some of the b...
Source: The Health Care Blog - November 12, 2017 Category: Consumer Health News Authors: John Irvine Tags: Uncategorized Source Type: blogs
Technologies Change Health Insurance: The Most Innovative Ventures
The accumulation of medical data enables health insurance companies to move from the 100-year-old concept of reactive care to preventive medicine. The future points to simple, fast and highly personalized insurance plans based on information from the healthcare system and data from health sensors, wearables, and trackers. Here is the changing health insurance scene and its most innovative solutions!
Health insurance systems are unsustainable partly due to costly chronic diseases
According to OECD predictions, exceeding budgets on health spending remains an issue for OECD countries. Maintaining today’s healthcare systems...
Source: The Medical Futurist - October 31, 2017 Category: Information Technology Authors: nora Tags: Future of Medicine Healthcare Design big data chronic illness digital digital health gc3 health data health insurance healthcare data technology trackers wearables Source Type: blogs
Founder and Owner of Insys Arrested
Late last week, John N. Kapoor, the founder and majority owner of Insys Therapeutics, Inc., was arrested and charged with leading a conspiracy to profit by using bribes and fraud to cause the illegal distribution of a Fentanyl spray intended for cancer patients experiencing breakthrough pain.
The superseding indictment includes allegations of RICO conspiracy, conspiracy to commit mail and wire fraud, and conspiracy to violate the Anti-Kickback law. It also includes additional allegations against former Insys executives and managers who were initially indicted in December 2016.
The Justice Department claims that Kapoor an...
Source: Policy and Medicine - October 30, 2017 Category: American Health Authors: Thomas Sullivan - Policy & Medicine Writing Staff Source Type: blogs
Pharmaceutical Companies and PBMs Helped to Create Our Opioid Crisis
I have blogged previously about the role of PBMs in shipping drugs to retail drug stores that placed suspiciously high drug orders (see:Drug Distributor McKesson Pays Record Penalty For Suspicious Opioid Orders). The role of the Sackler family, owners ofPurdue Pharma, in aggressively pushing Oxycontin is also now coming to light (see:The Sackler Family: best known for philanthropy, they made billions promoting Oxycontin;Report: Stamford company confirms DOJ probe). Let's face facts. You can't have a country-wide epidemic of prescription drugs without the connivance of some of the major corporations. Some of t...
Source: Lab Soft News - October 27, 2017 Category: Laboratory Medicine Authors: Bruce Friedman Tags: Healthcare Business Medical Ethics Pharmaceutical Industry Source Type: blogs
Scum of the earth award
May I have the envelope please? And the winner is:John Kapoor. Actually I was originally going to give it tothis schtickdreck, Rhode Island physician (now defrocked) Jerrold Rosenberg. Rosenberg took $188,000 from Kapoor ' s company to prescribe an opioid formulation containing fentanyl. It is only approved for what ' s called " breakthrough " cancer pain, which means pain that can ' t be controlled by more conventional opioid formulations. Since the patients didn ' t actually have cancer, Rosenberg also had to defraud their insurance companies. The story doesn ' t say whether any of his patients became opioid addicts, or ...
Source: Stayin' Alive - October 26, 2017 Category: American Health Source Type: blogs
